Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,027,775
-
Share change
-
-6,848,495
-
Total reported value
-
$70,693,154
-
Put/Call ratio
-
42%
-
Price per share
-
$3.07
-
Number of holders
-
88
-
Value change
-
-$39,154,608
-
Number of buys
-
41
-
Number of sells
-
45
Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q1 2018
As of 31 Mar 2018,
TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,027,775 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Man Group plc, STATE STREET CORP, Broadfin Capital, LLC, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, BAKER BROS. ADVISORS LP, and Tekla Capital Management LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.